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Individuals with Angelman syndrome (AS) suffer sleep disturbances that severely impair quality of life. Whether these disturbances arise
from sleep or circadian clock dysfunction is currently unknown. Here, we explored the mechanistic basis for these sleep disorders in a
mouse model of Angelman syndrome (Ube3am/p mice). Genetic deletion of the maternal Ube3a allele practically eliminates UBE3A
protein from the brain of Ube3am/p mice, because the paternal allele is epigenetically silenced in most neurons. However, we found that
UBE3A protein was present in many neurons of the suprachiasmatic nucleus—the site of the mammalian circadian clock—indicating
that Ube3a can be expressed from both parental alleles in this brain region in adult mice. We found that while Ube3am/p mice
maintained relatively normal circadian rhythms of behavior and light-resetting, these mice exhibited consolidated locomotor activity
and skipped the timed rest period (siesta) present in wild-type (Ube3am/p) mice. Electroencephalographic analysis revealed that
alterations in sleep regulation were responsible for these overt changes in activity. Specifically, Ube3am/p mice have a markedly
reduced capacity to accumulate sleep pressure, both during their active period and in response to forced sleep deprivation. Thus, our data
indicate that the siesta is governed by sleep pressure, and that Ube3a is an important regulator of sleep homeostasis. These preclinical
findings suggest that therapeutic interventions that target mechanisms of sleep homeostasis may improve sleep quality in individuals
with AS.
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Introduction
Angelman syndrome (AS) is a severe neurodevelopmental disor-
der characterized by developmental delay, seizures, lack of
speech, ataxia, and profound sleep disturbances (Williams et al.,
2006; Dan, 2009; Thibert et al., 2013). These sleep disturbances
include reduced need for sleep, irregular sleep/wake cycles, and
difficulty initiating and maintaining sleep. While sleep distur-
bances are more severe during childhood, they persist in roughly
70% of adults with AS (Walz et al., 2005; Pelc et al., 2008; LarsonReceived June 8, 2015; revised Aug. 21, 2015; accepted Aug. 25, 2015.
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Significance Statement
Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by loss of expression of the maternal copy of the UBE3A
gene. Individuals with AS have severe sleep dysfunction that affects their cognition and presents challenges to their caregivers.
Unfortunately, current treatment strategies have limited efficacy due to a poor understanding of the mechanisms underlying sleep
disruptions in AS. Here we demonstrate that abnormal sleep patterns arise from a deficit in accumulation of sleep drive, uncov-
ering the Ube3a gene as a novel genetic regulator of sleep homeostasis. Our findings encourage a re-evaluation of current treat-
ment strategies for sleep dysfunction in AS, and suggest that interventions that promote increased sleep drive may alleviate sleep
disturbances in individuals with AS.
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et al., 2015). The finding that AS individuals can exhibit damp-
ened rhythms of circulating melatonin (Takaesu et al., 2012) has
led to the suggestion that circadian clock dysfunction contributes
to the sleep disturbance. However, melatonin treatments have
had limited success in improving sleep quality in individuals with
AS (Braam et al., 2008; Pelc et al., 2008). Thus, there is a need to
better understand the neurobiology underlying disturbed sleep in
individuals with AS to guide more effective behavioral therapies
and pharmacological treatments.
The sleep deficits in AS presumably arise from a deficiency in
UBE3A, as mutation or deletion of the maternally inherited allele
of the UBE3A gene causes AS (Kishino et al., 1997; Matsuura et
al., 1997; Sutcliffe et al., 1997; Williams et al., 2010; Mabb et al.,
2011). The paternally inherited UBE3A allele is epigenetically si-
lenced in almost all neurons (Albrecht et al., 1997; Rougeulle et
al., 1997; Yamasaki et al., 2003); thus, the loss of a functional
maternal UBE3A allele causes a nearly complete loss of UBE3A
protein in most regions of the mammalian brain (Gustin et al.,
2010; Judson et al., 2014). In mice, this epigenetic silencing of the
paternal allele is found in neurons by the first postnatal week,
while glial cells preserve biallelic expression of Ube3a into adult-
hood (Judson et al., 2014). The UBE3A protein (also known as
E6-AP) is an E3 ubiquitin ligase that targets substrate proteins for
proteasomal degradation (Scheffner et al., 1993). In Drosophila,
loss of the UBE3A protein disrupts circadian patterns of locomo-
tor activity (Wu et al., 2008; Gossan et al., 2014). In mammals,
maternal deletion or RNAi-mediated knockdown of Ube3a can
cause subtle alterations in circadian rhythmicity, presumably by
stabilizing the core clock protein BMAL1 (Gossan et al., 2014; Shi
et al., 2015). Together, these findings suggest a role for UBE3A in
regulating circadian clock function in individuals with AS,
potentially contributing to the sleep disturbances in individuals
with AS.
The epigenetic mechanisms silencing expression of the pater-
nal Ube3a allele are nearly identical in mouse and human brains
(Nicholls and Knepper, 2001; Lalande and Calciano, 2007).
Mouse models of AS (Ube3am/p mice) display a number of
traits that resemble core features of AS, including seizure suscep-
tibility, ataxias, memory impairments, and sleep deficits (Jiang et
al., 1998; Miura et al., 2002; Colas et al., 2005; van Woerden et al.,
2007; Egawa et al., 2012; Huang et al., 2013). To provide insight
into sleep dysregulation in individuals with AS, we therefore used
the mouse model to explore mechanisms by which maternal
Ube3a deletions might contribute to disrupted sleep regulation.
We find that maternal Ube3a deletion does not significantly alter
circadian rhythmicity, but markedly disrupts sleep homeostasis,
especially the accumulation of sleep pressure. Thus, our findings
support a role for Ube3a as a novel sleep-regulatory gene, and
suggest that deficient sleep-pressure accumulation, rather than
altered circadian clock function, is likely the major defect under-
lying sleep disturbances in AS.
Materials and Methods
Animals and circadian behavior. Ube3am/p mice (Jiang et al., 1998) and
their wild-type littermates were used for circadian behavior and sleep
studies and were obtained from Jackson Laboratory (stock #016590).
Mice were 6 – 8 weeks old when studies began, and 10 –12 months old
when killed for suprachiasmatic nucleus (SCN) dissection and quantita-
tive PCR (qPCR) analysis. Mice were individually housed and main-
tained under a 12 h light/12 h dark cycle (LD 12:12, light: 150 lux)
unless indicated otherwise, with ad libitum access to food (Purina Rodent
Chow #5001) and water, in rooms maintained at 22  2°C ambient
temperature. To monitor behavioral rhythms, mice were transferred to
cages, equipped with running wheels, inside of secondary light-
controlled enclosures (Evans et al., 2013). Wheel-running activity was
monitored continuously and analyzed using Clocklab (Actimetrics). At
least 2 weeks were allowed between manipulations of the lighting condi-
tions to ensure mice were stably entrained. Circadian periods were de-
termined using regressions through activity onsets across the 21 d period
in constant darkness ( 2 periodogram analysis produced identical
results), and phase shifts were measured as described previously
(DeBruyne et al., 2006).
Rhythmic gene expression. At the indicated times in the LD 12:12 cycle,
mice were killed and the SCN/anterior hypothalami were dissected out
and flash-frozen. RNA was extracted using TRI Reagent (Molecular Re-
search Center), including 1 l of GlycoBlue (Ambion) per SCN as a
precipitation carrier, and reverse-transcribed using the high-capacity
cDNA reverse transcription kit (Life Technologies). qPCR was per-
formed using SsoAdvanced Sybr Green Supermix (Bio-Rad) on a CFX96
real-time detection system (Bio-Rad). All data are plotted relative to
Gapdh as a loading control (DiTacchio et al., 2011). Dbp, RevErb, and
Bmal1 primers were described in (Wu et al., 2008), and the Per1 and Cry1
primers were described previously (Anand et al., 2013). Rhythms in
Bmal1-Luc U2OS cells were monitored using a Lumicycle (Actimetrics)
starting 48 h after transfecting cells with 10 pmol of AllStars negative
control (Qiagen) or siRNAs directed against Ube3a (Qiagen, catalog
#GS7337) as described previously (Yamazaki and Takahashi, 2005; Baggs
et al., 2009). Knockdown was verified via Western blot with anti-UBE3A
antibodies from Sigma-Aldrich (catalog #SAB1404508).
Immunohistochemistry. Ten-to-sixteen-week-old male and female
mice (Ube3am/p or Ube3am/p) were housed under a LD 12:12 cycle
and given ad libitum access to food and water before perfusion. At the
indicated zeitgeber times (ZTs), mice were deeply anesthetized with so-
dium pentobarbital (60 mg/kg, i.p.) before transcardial perfusion with
room-temperature PBS immediately followed by room-temperature
phosphate-buffered paraformaldehyde, pH 7.3. Perfused brains were re-
moved from the skull and postfixed overnight at 4°C. Fixed brains were
cryoprotected in 10, 20, and 30% sucrose in PBS at 4°C for 12 h each,
before being frozen in dry ice and sectioned coronally at 40 m on a
freezing sliding microtome (Thermo Scientific). Sections were stored in a
cryopreservative solution (v/v: 45% PBS, 30% ethylene glycol, 25% glyc-
erol) at 20°C before free-floating immunohistochemistry.
Tissue sections were washed several times in PBS and blocked in PBS
with 5% normal goat serum and 0.2% Triton X-100 (NGST) for 1 h at
room temperature. Blocked tissue sections were incubated with primary
antibodies diluted in NGST for 48 h at 4°C. Sections were then washed
several times in PBS containing 0.2% Triton X-100 before incubation
with secondary antibodies (diluted in NGST) for 1 h at room tempera-
ture. The following primary antibodies were used: mouse anti-UBE3A
(1:1000, clone 3E5; Sigma-Aldrich, catalog #SAB1404508) and rabbit
anti-PER2 (1:5000, clone R38; Millipore, catalog #AB2202). The follow-
ing secondary antibodies were used at a concentration of 1:500: goat
anti-mouse IgG1 Alexa 568 (Millipore, catalog #A21124), goat anti-
mouse IgG2A Alexa 488 (Millipore, catalog #A21131), goat anti-rabbit
Alexa 568 (Millipore, catalog #A11011), and goat anti-rabbit Alexa 633
(Millipore, catalog #A21071). In all experiments, 4,6-diamidino-2-
phenylindole (DAPI) was added during the secondary antibody incuba-
tion at a concentration of 700 ng/ml for nuclear counterstaining.
Perfusions, tissue sectioning, and immunostaining were performed by
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experimenters blind to genotype. Brain sections compared within figures
were stained within the same experiment under identical conditions.
Confocal microscopy and image analysis. Immunostained sections con-
taining the SCN were imaged using a Zeiss LSM 710 confocal microscope
equipped with ZEN Imaging Software (Zeiss). Single-plane optical slices
1.8 m thick were acquired using a 20 objective (Plan-Apochromat
20/0.8 M27) at a pixel dwell time of 3.15 s with 4 averaging. Images
containing the SCN, third ventricle, and surrounding hypothalamic re-
gions were acquired by tiling 3  3 micrographs of 1024  1024 pixels
that were stitched using ZEN software. Images compared within figures
were acquired using identical acquisition parameters. All images to be
compared underwent identical manipulations.
Quantification of immunofluorescent signals was performed in
ImageJ (http://imagej.nih.gov/ij/). Regions bounding the left and right
SCN were created manually for each image using the DAPI channel by an
experimenter blind to genotype. The regions were applied to the UBE3A
or PER2 channels, and the mean gray values within SCN regions were
measured. An oval region of a standard size across all images (150  300
m) was also placed in the adjacent lateral hypothalamus, and the aver-
age intensity within this region was subtracted from the average intensity
in the SCN to normalize the SCN intensity value. Values in the lateral
hypothalamus regions did not change across ZTs. Sections containing
rostral, central, and caudal regions of the SCN were imaged for all con-
ditions in a balanced fashion and included for quantification.
Surgery. Electroencephalogram (EEG) and electromyogram (EMG)
electrodes for polysomnographic recording of sleep–wake states were
implanted in anesthetized mice. Electrodes were implanted by surgeons
blind to the experiment. A prefabricated head mount (Pinnacle Technol-
ogies) was used to position four stainless-steel epidural screw electrodes.
Frontal and ground electrodes were located 1.5 mm anterior to bregma
and 1.5 mm on either side of the central suture, and parietal/occipital and
common references were located 3.5 mm posterior to bregma and 1.5
mm on either side of the central suture. Electrical continuity between the
screw electrodes and headmount was aided by the use of silver epoxy.
EMG activity was monitored using stainless-steel Teflon-coated wires
integrated into the headmount and inserted bilaterally into the nuchal
muscle. The headmount (integrated 2  3 pin grid array) was secured to
the skull with dental acrylic. Over the next 36 h, mice were given Bu-
prenex (buprenorphine; 2 mg/kg subcutaneously) once every 12 h to
control pain. All procedures were performed on a heating pad; mice were
allowed to recover for 14 d before being transferred to sleep-recording
chambers.
EEG/EMG recordings. Following recovery, mice were placed in a sleep-
recording chamber and connected to a lightweight tether connected to a
low-resistance commutator mounted over the cage (Pinnacle Technolo-
gies), allowing complete freedom of movement throughout the cage.
Except for the recording tether, conditions in the recording chamber
were identical to those in the home cage. Mice were allowed 7 addi-
tional days to acclimate to the tether. Recording of EEG and EMG wave-
forms began at ZT 0 (light onset in the 12 h light/dark cycle). Following a
24 h baseline recording, mice were sleep deprived during the first 6 h of
the light phase (ZT 0 – 6) by gentle handling (introduction of novel ob-
jects into the cage, tapping on the cage, and, when necessary, delicate
touching) and allowed an 18 h recovery opportunity (ZT 6 –24). Data
acquisition was performed on a PC running Sirenia Acquisition software
(Pinnacle Technologies), a software system designed specifically for
polysomnographic recording in rodents. EEG signals were low-pass fil-
tered with a 30 Hz cutoff and collected continuously at a sampling rate of
400 Hz. After collection, all waveforms were classified in 2 s epochs by a
trained observer blind to the genotype and experimental condition (us-
ing both EEG leads and EMG) as wake (low-voltage, high-frequency
EEG; high-amplitude EMG), nonrapid-eye-movement (NREM) sleep
(high-voltage, mixed-frequency EEG; low-amplitude EMG), or rapid-
eye-movement (REM) sleep [low-voltage EEG with a predominance of
theta activity (6 –10 Hz); very low amplitude EMG]. EEG epochs deter-
mined to have artifact (interference caused by scratching, movement,
eating, or drinking) was excluded from analysis. Artifact comprised 5%
of all recordings used for analysis. Analysis of NREM delta power and
NREM spectral distribution was accomplished by applying a fast Fourier
transformation to raw EEG waveforms. Only epochs classified as NREM
sleep were included in this analysis. Delta power was measured as spectral
power in the 0.5– 4 Hz frequency range, and expressed as a percentage of
total spectral power in the EEG signal (0.5–100 Hz) during that time
period.
Wave incidence. Analysis was performed using custom-written func-
tions in Igor Pro 6.2 (WaveMetrics) as previously described (Ehlen et al.,
2013). Briefly, raw EEG signals from the frontal-parietal derivation were
bandpass filtered in the frequency range indicated using a Butterworth
fourth-order bandpass filter (Igor Pro routine FilterIIR). Peaks in the
filtered data were detected as negative deflections between two zero
crossings. The amplitudes (maximum negative deflection from zero
crossing) of all peaks detected in an entire 24 h period were then deter-
mined. The upper 30% of peak amplitudes that occurred in epochs
scored as wake were then counted and expressed as peaks per minute
(wave incidence). The wave incidence data were then combined into 2 h
bins for graphing and statistical analysis. Short durations of wake (10
epochs) were excluded from analysis.
Statistics. Data are expressed as mean  SEM unless otherwise speci-
fied. Quantified data were plotted in Microsoft Excel or GraphPad Prism
6 (GraphPad Software), and statistical analysis was performed using Stat-
Plus (AnalystSoft) or GraphPad Prism 6. Two-tailed Student’s t tests,
one-way ANOVA, and two-way ANOVA were performed as indicated,
using corrections for multiple comparisons and post hoc tests as specified
in the text. For all statistical tests, p  0.05 was considered statistically
significant.
Study approval. All animal procedures were approved by the institu-
tional animal care and use committees of either the Morehouse School of
Medicine or the University of North Carolina School of Medicine, and
performed in accordance with the guidelines of the U.S. National Insti-
tutes of Health.
Results
Circadian clock function is largely intact in AS model mice
To assess whether perturbed circadian rhythms might contribute
to sleep disturbances associated with AS, we placed Ube3am/p
mice (congenic on C57BL/6J background) and wild-type
(Ube3am/p) littermate controls in cages equipped with run-
ning wheels, and continuously recorded wheel-running behav-
ior. Activity levels were similar between the two genotypes (Fig.
1A,B), suggesting that the impaired motor coordination and re-
duced activity in open-field tests reported in Ube3am/p mice
(Jiang et al., 1998; Huang et al., 2013) does not impair wheel-
running activity. We asked whether maternal loss of Ube3a alters
the period of circadian behavioral rhythms in constant darkness,
or the clock’s ability to adjust its timing to aberrant light-
schedules such as simulated jet lag, as a defect in either could
signify impaired clock function. We found that neither circadian
period nor the ability of the clock to shift in response to altered
lighting paradigms was significantly changed in Ube3am/p
mice (Fig. 1C–E). Thus, at a behavioral level, the circadian system
appears to function normally in Ube3am/p mice.
Because behavioral circadian rhythms are linked to the rhyth-
mic expression of several “clock genes” in the SCN, we also
examined the expression patterns of several clockwork genes in
the SCN of Ube3am/p and wild-type mice (Zylka et al., 1998;
Partch et al., 2014; Fig. 2A). Maternal loss of Ube3a had no
marked effect on diurnal expression of the clock genes Per1,
RevErb, Cry1, and Bmal1, or the circadian output gene Dbp (Fig.
2A). Likewise, rhythms in immunoreactivity of the clock protein
PER2 were also indistinguishable in SCN of Ube3am/p and
wild-type mice (Fig. 2B,C). Thus, the molecular clockwork in the
SCN of Ube3am/p mice displays no obvious differences from
that of littermate controls, consistent with their unaltered circa-
dian behavioral rhythmicity.
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Previous work had established that, due to silencing of the
paternal allele, Ube3a expression in mature neurons arises from
the maternal allele (Rougeulle et al., 1997; Yamasaki et al., 2003;
Judson et al., 2014). We therefore expected UBE3A protein to
also be absent from the SCN of Ube3am/p mice. To confirm
this, we examined UBE3A protein expression patterns in wild-
type and Ube3am/p mice using an established immunofluores-
cence protocol that shows high specificity and sensitivity for
UBE3A immunofluorescent signal (Judson et al., 2014). In wild-
type mice, UBE3A protein was expressed in nearly all cells in the
SCN and surrounding hypothalamus, and did not cycle in abun-
dance (Fig. 2B,D). Much to our surprise, we found UBE3A pro-
tein was also robustly expressed throughout the SCN of
Ube3am/p mice (Fig. 2B,D,E). As expected in Ube3am/p
mice, regions surrounding the SCN exhibited no detectable
UBE3A, but the SCN maintained constitutive UBE3A levels at
50% compared with wild-type SCN across the circadian day
(Fig. 2D). Visual inspection suggested that both the number of
cells expressing UBE3A and the intensity of labeling were reduced
in the SCN of Ube3am/p mice. We found UBE3A staining to be
completely absent from the SCN of homozygous Ube3a-null
mice (Fig. 2E), confirming the specificity of the antibody. The
persistent expression of UBE3A in the SCN of Ube3am/p mice
must originate from the paternal allele, implying that, unlike in
most other brain regions, Ube3a expression is biallelic in the SCN
of adult mice.
Since UBE3A is still present in the SCN of maternally deleted
Ube3a mice, it is possible that the remaining UBE3A is sufficient
to maintain normal clock function in the SCN. Homozygous
Ube3a knock-out mice on C57BL/6J background, however, are
born at sub-Mendelian rates, and survivors exhibit morphologi-
cal complications, including reduced body and brain weights
(Jiang et al., 1998; M.C. Judson and B.D. Philpot, unpublished
observations). These systemic influences of the mutation limit
effective examination of behavioral circadian rhythms in adult
homozygous Ube3a-null mice. We therefore opted to determine
whether RNAi-mediated knockdown of Ube3a had substantial
effects on circadian rhythmicity in the well established Bmal1-
luciferase U2OS cell model (Baggs et al., 2009; Zhang et al., 2009).
Consistent with similar experiments in NIH3T3 cells (Gossan et
al., 2014), we found that UBE3A knockdown to 20% of control
levels had a small but significant effect on circadian period,
lengthening it by 36 min (scrambled siRNA negative control,
27.2  0.1 h; Ube3a-siRNA treated, 27.8  0.1 h; p  0.05, Stu-
dent’s t test; n 	 7– 8 combined from two independent experi-
ments). Thus, depletion of UBE3A beyond levels seen in the SCN
of Ube3am/p mice slightly alters circadian clock function, con-
sistent with its proposed role in the mammalian circadian clock-
Figure 1. Circadian behavior is largely intact in AS model mice. A, Double-plotted wheel-running records obtained from wild-type (Ube3am/p) and AS model (Ube3am/p) mice on 12 h
light/dark cycle (LD) and in constant darkness (DD). Running activity is indicated by tick marks, and subsequent days are plotted to the right and below each previous day. The shading illustrates the
light cycle schedules. B, Average daily wheel-running counts over the last 14 d in LD. Means  SEM, n 	 11 Ube3am/p or 9 Ube3am/p mice (two-tailed t test, p 
 0.05). C, Average circadian
free-running periods (SEM) measured over 21 d in DD from the same animals in B (two-tailed t test, p 
 0.05). D, Circadian resetting in response to 4 h light pulses applied early (ZT 13–17) or
late (ZT 20 –24) during the night preceding DD. The number of hours the circadian clock was shifted is plotted as mean  SEM from 11 Ube3am/p and 8 Ube3am/p mice (two-tailed t test, p 

0.05). E, Example records (left) and plot of activity onset timing (right) during re-entrainment to a simulated 6 h advance jet lag. The activity onset plot represents meanSEM from 21 Ube3am/p
and 19 Ube3am/p mice, combined from two independent experiments. Activity onset time was not significantly different between genotypes on any day (two-tailed t test on each day, p 
0.05).
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work (Gossan et al., 2014; Shi et al., 2015). However, these data
suggest that substantial dysfunction of the circadian clockwork is
unlikely in homozygous Ube3a knock-out mice. Together, our
data suggest (1) that maternal deletion of Ube3a does not mark-
edly disrupt circadian clock function or its regulation of locomo-
tor activity, and (2) that deficits in circadian rhythmicity may not
be the major contributing mechanism for disturbed sleep pat-
terns in AS.
Maternal Ube3a deletion eliminates the active-phase
rest period
In contrast to the relatively normal circadian locomotor activity
seen in Ube3am/p mice, maternal loss of Ube3a dramatically
altered the organization of their daily activity patterns (Fig. 3A).
Wild-type mice typically became active at lights-off and re-
mained active for the first half of the night. This primary bout of
activity was followed by a rest period with little locomotor activity
Figure 2. AS model mice display normal molecular rhythmicity and persistent UBE3A expression in the SCN. A, mRNA levels of the indicated genes measured by qPCR across the day in
SCN. Each data point represents the mean  SEM from four to six mice per genotype and time. B, Representative images of UBE3A and PER2 immunostaining in coronal sections through
the SCN from adult Ube3am/p or Ube3am/p mice perfused at the indicated ZTs. DAPI was used as a nuclear counterstain. 3V, Third ventricle; ox, optic chiasm. Scale bar, 100 m.
C, Quantification of PER2 immunofluorescence intensity in SCN of adult Ube3am/p or Ube3am/p mice killed at 4 h intervals across the day. There was no difference between the two
genotypes in rhythmic expression patterns of PER2 in the SCN (two-way ANOVA, main effect of genotype: F(1,48) 	 0.113, p 	 0.738; main effect of ZT: F(5,48) 	 24.0, p  0.0001). Each
point represents the mean  SEM of five mice per genotype and time, normalized to peak intensity (ZT 12, Ube3am/p). D, Quantification of UBE3A immunofluorescence intensity in
the same sections as C. There was no significant main effect of ZT on UBE3A abundance within each genotype (two-way ANOVA: F(5,48) 	 1.65, p 	 0.166). However, there was an effect
of genotype on UBE3A expression (two-way ANOVA: F(1,48) 	 24.2, p  0.0001). Each point represents the mean  SEM of five mice per genotype and time, normalized to peak intensity
(ZT 0, Ube3am/p). E, Low-magnification and high-magnification images of immunofluorescent staining for UBE3A and DAPI in coronal sections through the SCN from adult
Ube3am/p, Ube3am/p, and Ube3am/p mice. High-magnification images show expression of UBE3A in a subset of SCN neurons (pink boxes in left images), but not in a
neighboring region of non-SCN hypothalamus (blue boxes) in Ube3am/p mice. DAPI counterstain demarcates the dense population of cells that make up the SCN. Scale bars: left, 100
m; right, 25 m.
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that lasted 2–3 h followed by a second bout of activity. This rest
period (also known as “nocturnal break” or “siesta”) is typically
observed in studies of sleep and locomotor activity in this strain
of mice (C57BL/6J; Valentinuzzi et al., 1997; Challet et al., 2001;
Dudley et al., 2003). The remarkably precise timing of the rest
period is readily apparent in 14 d average-activity profiles of all
wild-type mice in our study (Fig. 3B,C). Like wild-type mice,
Ube3am/p mice had an activity onset immediately after lights-
off. However, locomotor activity in these mice was restricted to a
single consolidated bout that persisted throughout most of the
night. Unlike wild-type mice, Ube3am/p mice did not display
any consistent rest periods during the night (Fig. 3A,B). The
Figure 3. Reorganization of activity patterns in AS model mice eliminates the active-phase rest period. A, Typical wheel-running records depicting the pattern of activity over 17 d in 12 h
light/dark cycle (LD12:12). Note the striking difference between genotypes in the nighttime activity pattern (gray shading). B, Average daily activity profiles over 14 d in LD12:12 of Ube3am/p
(black) and Ube3am/p (red) mice (meanSEM, n	9 –11 mice per genotype). Bracket indicates the primary difference in activity profiles between genotypes. C, Individual 14 d average-activity
profiles for each of the mice included in B. Note the siesta-like break in activity (black arrow) present in all the Ube3am/p records (black), but absent from the Ube3am/p records (red). D–I,
Comparison of activity pattern characteristics between Ube3am/p and Ube3am/p mice on LD12:12. Means  SEM are shown (n 	 11 Ube3am/p; n 	 8 Ube3am/p). Asterisk indicates
significant differences (two-tailed t test on each day, p  0.05). Bout calculations were derived from each individual’s average-activity profile shown in C. A bout was defined as 
30 min of
continuous activity preceded and followed by a period of inactivity for 
30 min, measured from 11 d average-activity profiles during LD12:12.
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absence of this rest period was highly penetrant; the genotype of
each individual could be accurately predicted by its activity pro-
file (Fig. 3C).
Overall daily activity levels were comparable to those of wild-
type mice (Fig. 1B), suggesting that the Ube3am/p mice were
not simply more active. Instead, Ube3am/p mice ended their
nightly activity nearly 2 h earlier than wild-type mice, despite a
slightly delayed activity onset (Fig. 3D-G). Thus, Ube3am/p
mice completed their main bout of activity at approximately the
same time wild-type mice began their second bout of activity
(Fig. 3B). Consequently, Ube3am/p mice were active over a
2-h-shorter portion of the 12 h night (Fig. 3H), despite having
comparable levels of total activity (Fig. 3I). Extending the dark
period by 6 h (LD 6:18) lengthened the total duration of activity
in both genotypes as expected, but did not induce a “second
bout” of activity in Ube3am/p mice (data not shown). This
indicates that the missing rest period in Ube3am/p mice is not
due to a change in its timing relative to the normal 12 h light/dark
cycle. We conclude that the loss of maternal Ube3a alters the
nighttime distribution of locomotor behavior, eliminating a
timed rest period that normally separates locomotor activity into
discrete bouts.
AS model mice have altered sleep regulation
Having determined that circadian rhythmicity was largely unaf-
fected in Ube3am/p mice, we explored whether changes in sleep
contribute to their altered activity profiles. Overall, polysomno-
graphic findings were consistent with the wheel-running activity
of both genotypes (Fig. 4A,B). Both strains displayed high
amounts of sleep during the day and low amounts during the 12 h
night (Fig. 4B), typical of nocturnal rodents. Both wild-type and
Ube3am/p mice slept for most of the
day, with no obvious differences in
amounts of total sleep, wake, or overall
sleep fragmentation between genotypes
(data not shown). Thus, sleep amount was
not dramatically altered in Ube3am/p
mice during the primary rest period for
mice.
In contrast, sleep patterns during the
dark were dramatically altered by the loss
of maternal Ube3a. The distribution of
sleep during the dark period in wild-type
C57BL/6 mice was characteristic of this
strain (Huber et al., 2000; Wisor et al.,
2008; Paul et al., 2009). Wild-type mice
slept little during the night, except for a
rest period that peaked at ZT 21, in which
sleep was predominant (Fig. 4B). The tim-
ing of this nighttime siesta corresponded
well to the rest period in locomotor activ-
ity (compare Figs. 3B, 4B). In contrast to
the wild-type mice, Ube3am/p mice
slept at a nearly constant level throughout
the dark period (Fig. 4B; two-way
ANOVA for genotype  time-of-day in-
teractions in total sleep; p  0.001).
Ube3am/p mice spent more time sleep-
ing and less time awake over the first part
of the night compared with wild-type
controls, and conversely slept less than
wild-type mice later in the night due to the
lack of the siesta (Fig. 4B). The consistent
level of sleep across the dark period suggests that the lack of siesta,
and associated rest period in locomotor activity, may reflect a
marked dysregulation in sleep homeostasis in Ube3am/p mice.
To further explore sleep regulation in Ube3am/p mice, we
assessed the architecture of REM and NREM (or slow-wave)
sleep across the 24 h day (Fig. 5A–F). The overall pattern of REM
sleep displayed by wild-type mice mimicked the pattern of
total sleep, with high levels during the day and low levels during
the early night that increased to a peak during the siesta (Fig. 5A).
The REM sleep pattern in Ube3am/p mice was similar to the
wild-type pattern, with the important exception that these mice
displayed no increase in REM sleep during late night, when wild-
type mice exhibit a siesta (Fig. 5A). The loss of siesta REM sleep
resulted in a substantial (20%) reduction in the total amount of
daily REM sleep in Ube3am/p mice (Ube3am/p, 64  2 min;
wild type, 80  5 min; t(12) 	 2.72, p 	 0.019). This decrease in
REM sleep was due to a reduction in the number of REM bouts
without a significant change in REM bout duration (Fig. 5B,C),
perhaps secondary to the effects on NREM sleep regulation.
The overall architecture of NREM sleep displayed by both
genotypes of mice was reminiscent of their respective patterns of
total sleep (Fig. 5D). Wild-type mice exhibited very little NREM
sleep just after lights-off that progressively increased and peaked
during the siesta. Ube3am/p mice displayed a quite different
pattern of NREM sleep throughout the night (Fig. 5D).
Ube3am/p mice spent more time in NREM sleep during the
early night (ZT 14), and less NREM sleep during the late night
(ZT 21). These differences reflect a change in sleep–wake archi-
tecture without alterations in total amounts of daily NREM sleep
(total daily NREM sleep, Ube3am/p, 589  15 min; wild type,
599  19 min; t(12) 	 0.4, p 	 0.69).
Figure 4. AS model mice have altered sleep–wake distribution. A, Representative polysomnographic recordings for
Ube3am/p and Ube3am/p mice in each vigilance state. B, Total sleep or wake in Ube3am/p and Ube3am/p mice,
recorded over an uninterrupted 24 h period in 12 h light/dark cycle. Data are shown as percentage of each 2 h block spent asleep or
awake within each mouse, averaged within genotypes (mean  SEM; n 	 6 Ube3am/p or n 	 8 Ube3am/p mice). Note the
difference in sleep/wake amounts between genotypes across the night (indicated by the gray shading). *p  0.008 between
genotypes at the indicated times ( post hoc t test; Bonferroni corrected).
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Maternal Ube3a loss had a striking effect on the architecture of
NREM sleep, as reflected by changes in both NREM bout number
and duration. In wild-type mice, shorter and fewer bouts of
NREM sleep occurred during the first few hours of the dark phase
and progressively increased to a peak during the siesta (Fig.
5E,F). Ube3am/p mice had NREM bout durations that were at
their shortest near dark onset, but unlike wild-type mice, NREM
bouts remained short for a majority of the dark period (Fig. 5F).
The number of NREM bouts also remained high during the early
night in Ube3am/p mice. These results show that Ube3am/p
mice have more fragmented nighttime NREM sleep than wild-
type mice, suggesting that maternal Ube3a loss disrupts mecha-
nisms involved in initiating and maintaining NREM sleep during
the night.
AS mice have reduced accumulation of sleep pressure
The “two-process” model of sleep regulation posits that sleep is
primarily regulated by two biological processes: output signals
from the circadian clock, independent of sleep–wake history; and
homeostatic sleep “pressure,” which is driven by prior sleep–
wake history (Borbély, 1982). In this context, the changes in daily
sleep patterns in Ube3am/p mice might be driven by alterations
in either the circadian clock or homeostatic processes. Since cir-
cadian processes are largely preserved in Ube3am/p mice, we
decided to investigate the homeostatic drive to sleep.
NREM delta (0.5– 4 Hz) power is a measure of sleep intensity
and a well established marker of sleep pressure; it is positively
correlated with prior time spent awake, and sleep deprivation is
followed by increases in NREM delta power (Huber et al., 2000).
We found that NREM delta power declined during the day at an
equivalent rate for mice of both genotypes, suggesting that
Ube3am/p mice maintain a neurotypical ability to dissipate
sleep pressure during the day (Fig. 6A). In contrast, marked dif-
ferences in NREM delta power were observed during the night. In
wild-type mice, NREM delta power increased throughout the
night to a peak coincident with the siesta (Fig. 6A). In contrast,
Ube3am/p mice exhibited a considerably slower increase in
delta power, and thus sleep-pressure accumulation, throughout
the night (Fig. 6A). Normalizing 24 h average NREM delta power
to the 24 h average waking delta power for each mouse revealed
that NREM delta power was significantly lower in Ube3am/p
mice than in that of littermate controls (wild type, 179  3%;
Ube3am/p, 128  3%; t(13) 	 2.8, p 	 0.008, Student’s t test),
indicating the effect on delta power was specific to NREM sleep.
As a complementary measure of sleep-pressure accumulation
in wild-type and Ube3am/p mice, we also examined the inci-
Figure 5. REM and NREM sleep states are reduced and fragmented in AS model mice during the active phase. A, Time spent in REM sleep across the day in Ube3am/p and Ube3am/p mice.
Two-way ANOVA revealed significant main effects of time and genotype (main effect of time-of-day, F(11,1) 	 51.7, p  0.001; main effect of genotype, F(11,1) 	 8.2, p 	 0.015), as well as a
significant interaction of time-of-day and genotype (interaction: F(11,1) 	 4.0, p  0.001). B, Number of REM bouts across the day in Ube3a
m/p and Ube3am/p mice. Two-way ANOVA
revealed a significant main effect of time-of-day (F(11,1) 	 24.4, p  0.001) but not genotype (F(11,1) 	 1.8, p 
 0.20), and a significant interaction of time and genotype (interaction: F(11,1) 	 2.5,
p 	 0.006). C, Duration of REM bouts across the day in Ube3am/p and Ube3am/p mice. Two-way ANOVA revealed a statistically significant main effect of genotype (F(11,1) 	 9.6, p 	 0.009)
but not time (F(11,1) 	 2.3, p 	 0.15), and no interaction of time-of-day and genotype (F(11,1) 	 1.8, p 	 0.057). D, Time spent in NREM sleep during this period. Two-way ANOVA revealed a
significant main effect of time-of-day (F(11,1) 	 31.3, p  0.001) but not genotype (F(11,1) 	 0.24, p 	 0.63), and a significant interaction of time-of-day and genotype (F(11,1) 	 4.3, p  0.001).
E, Number of NREM bouts across the day in Ube3am/p and Ube3am/p mice. Two-way ANOVA revealed a significant main effect of time (F(11,1) 	 9.0, p  0.001) but not genotype (F(11,1) 	
2.4, p 	 0.15), and a significant interaction of time-of-day and genotype (F(11,1) 	 2.9, p 	 0.002). F, Duration of NREM bouts across the day in Ube3a
m/p and Ube3am/p mice. Two-way
ANOVA revealed a significant main effect of time-of-day (F(11,1) 	 4.0, p  0.001) but not genotype (F(11,1) 	 1.3, p 	 0.29), and a significant interaction of time and genotype (F(11,1) 	 1.9, p 	
0.044). Data in all panels are shown as percentages of time spent in each arousal state, bout number, or mean bout duration of each 2 h block within each mouse, averaged within genotypes
(mean  SEM; n 	 6 Ube3am/p or n 	 8 Ube3am/p mice). Asterisk indicates significant differences between genotypes at the indicated times ( p  0.05, post hoc t test; Bonferroni
corrected).
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dence of 2– 6 Hz waves that occur during epochs of the waking
EEG [wave incidence (I2– 6)]. I2– 6 is a measure of sleep pressure
experienced by animals while they are awake, and correlates
strongly with other measures of sleep pressure, including waking
theta power, but with better temporal resolution (Ehlen et al.,
2013). In wild-type mice, I2– 6 increased significantly across the
night (Fig. 6B; Student–Newman–Keuls post hoc, p  0.05). In
contrast, I2– 6 in Ube3a
m/p mice did not increase over the same
period, remaining consistent throughout the night (Fig. 6B; data
not shown), further supporting a deficiency in sleep-pressure
accumulation during the night in Ube3am/p mice.
The relatively constant levels of sleep, delta power, and I2– 6
during the night that occur with maternal Ube3a loss suggest that
Ube3am/p mice have a reduced need for a siesta as a conse-
quence of their relative inability to accumulate sleep pressure.
However, because Ube3am/p mice tend to sleep slightly more
than wild-type mice during the early night (Figs. 4, 5), it is unclear
whether these changes in nighttime sleep-pressure accumulation
were due to defects in sleep homeostasis or circadian clock out-
puts that directly regulate sleep–wake patterns. To distinguish
between these possibilities, we conducted a standard homeostatic
challenge by assessing changes in sleep pressure caused by forced
sleep deprivation during the day, when mice sleep the most (Bor-
bély and Neuhaus, 1979). Specifically, we sleep-deprived mice for
the first half of the day, ZT 0 – 6, and focused our analyses on
responses occurring during the second half of the day, ZT 6 –12.
Wild-type mice showed typical significant increases in NREM
sleep, delta power, and I2– 6 immediately (ZT 6 –12) after sleep
deprivation, indicating that sleep deprivation substantially in-
creased sleep pressure (Fig. 7). In contrast, sleep deprivation in
Ube3am/p mice did not significantly increase NREM sleep,
delta power, or I2– 6 (Fig. 7), indicating that Ube3a
m/p mice
have a distinct and specific deficit accumulating sleep pressure.
During the 18 h recovery period that followed sleep deprivation,
wild-type mice exhibited a significantly larger increase in NREM
delta power normalized to waking delta power when compared
with Ube3am/p mice (wild type, 193  3%; Ube3am/p, 121 
4%; t(11) 	 3.3, p 	 0.003, Student’s t test). Thus, together, our
data suggest that Ube3am/p mice have an impaired sleep ho-
meostatic mechanism that is responsible for the behavioral
changes associated with the loss of their siesta.
Discussion
We found that loss of maternal Ube3a produces a penetrant
reorganization of sleep–wake architecture across the night,
without substantially disrupting circadian rhythms in loco-
motor activity or molecular clockwork. Our findings suggest a
role for maternal Ube3a in regulating the accumulation of
sleep pressure during wakefulness, and identify Ube3a as a
novel sleep-regulation gene.
We observed a consistently timed rest period (siesta) in wild-
type mice during the latter part of the active phase, as previously
reported in C57BL/6 mice (Valentinuzzi et al., 1997; Challet et al.,
2001). In wild-type mice, this rest period was coincident with a
peak in sleep propensity, suggesting that it may be a product of
sleep-pressure accumulation during a long bout of wakefulness.
This timed rest period was absent in Ube3am/p mice. Our study
is the first to link sleep-pressure accumulation and the occur-
rence of a timed rest period, and suggests that Ube3am/p mice
may serve as a novel model for understanding the mechanisms
that control the timed rest period during the active phase.
By depriving mice of sleep during the day, when mice sleep the
most, we revealed that the effect of Ube3a loss on sleep pressure is
not limited to the active period. Ube3am/p mice have blunted
sleep drive following sleep deprivation compared with littermate
controls. Thus, Ube3am/p mice fail to accumulate sleep pres-
sure while they are awake, regardless of time of day. That
Ube3am/p mice exhibit NREM delta power levels that are com-
parable to wild-type mice during the early daytime (Fig. 6A, ZT 1)
suggests that Ube3am/p mice are capable of typical levels of
sleep pressure, but their failure to accumulate sleep pressure in
response to wakefulness suggests the possibility that the early-
morning sleep pressure may develop independent of wakeful-
ness. Ube3a may provide an entry point for deciphering the
circuitry and molecular mechanisms underlying sleep homeosta-
sis across both the active and inactive phases of the day.
Figure 6. AS model mice exhibit reduced nighttime sleep-pressure accumulation. A, NREM sleep intensity, as measured by delta power, is significantly reduced in Ube3am/p mice during the
latter portion of the night (interaction of time-of-day and genotype, F(5,1) 	 3.0, p  0.02; main effect of time-of-day, F(5,1) 	 7.3, p  0.001; main effect of genotype, F(5,1) 	 0.72, p 	 0.42).
Data represent NREM relative delta power (power 0.5– 4 Hz/total EEG power) and are presented as 2 h averages (n 	 6 Ube3am/p or n 	 8 Ube3am/p mice)  SEM. *p  0.05 between
genotypes at the indicated times ( post hoc t test; Bonferroni corrected). B, The increase in I2– 6 during the 12 h dark (wakeful) period is abolished in Ube3a
m/p mice. Representative EEG recordings
(black and red) are shown above bandpass-filtered versions (gray and dark red) of the same EEG recording. The incidence of peaks in the upper 30% by amplitude (maximum negative deflection
between two zero crossings; blue line denotes 30th percentile amplitude cutoff) in the filtered signal were counted in epochs scored as waking. I2– 6 has been previously validated as a measure of
sleep-pressure accumulation in awake mice (Ehlen et al., 2013). Arrowheads indicate detected peaks. I2– 6 significantly increased across the active period in Ube3a
m/p mice (black plot;
early night, ZT 12–14, vs late night, ZT 20 –22; Student’s paired t test, p  0.05). This measure of sleep pressure (I2– 6) failed to significantly accumulate in Ube3a
m/p mice (red plot;
paired t test, p 
 0.05).
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The effect of maternal Ube3a loss on sleep homeostasis ap-
pears to be independent of a substantial disruption in circadian
clock function in the SCN. Another group (Shi et al., 2015) re-
cently reported that the same AS model mouse line (Jiang et al.,
1998) exhibits a modest lengthening of circadian period (
0.5 h
change) in constant darkness and faster entrainment to experi-
mental jet lag. Our data trend in the same direction for both
measures; however, the effects did not reach significance in our
hands. We believe the discrepancy between studies highlights the
subtlety of the effect of maternal Ube3a deletion on circadian
Figure 7. AS model mice exhibit blunted recovery responses from sleep deprivation. A, Line plots, NREM sleep responses to sleep deprivation (SD) during ZT 0 – 6. Baseline sleep data are replotted
from Figure 5D for comparison. Bar graph, Comparison of the effect of sleep deprivation on NREM sleep amounts immediately after the sleep deprivation period (ZT 6 –12). Data are plotted as a
percentage of the baseline NREM sleep amount. Only wild-type mice (Ube3am/p) displayed a significant increase in NREM sleep following sleep deprivation. Asterisk indicates significant effect
of sleep deprivation ( p  0.05, Student’s paired one-tailed t test; n 	 4 Ube3am/p or n 	 8 Ube3am/p mice). B, Line plots, NREM relative delta power (power 0.5– 4 Hz/total EEG power)
during baseline sleep (replotted from Fig. 6A) and in response to sleep deprivation during ZT 0 – 6. Bar graph, Comparisons of the effect on average relative delta power between genotypes
immediately following sleep deprivation (ZT 6 –12). Only wild-type mice (Ube3am/p) displayed a significant increase in delta power following sleep deprivation. Asterisk indicates significant
effect of sleep deprivation ( p  0.05, Student’s paired one-tailed t test; n 	 4 Ube3am/p or n 	 8 Ube3am/p mice). C, Left, Representative EEG recordings of I2– 6, as described in Figure 6,
shown before and after the 6 h sleep-deprivation period. Note the increase in I2– 6 (arrowheads) in Ube3a
m/p mice in response to sleep deprivation. Right, I2– 6 before and after sleep deprivation.
I2– 6 significantly increased across the sleep-deprivation period in Ube3a
m/p mice (black plot; presleep deprivation, ZT 0 –1, vs postsleep deprivation, ZT 6 –7; paired t test, p  0.05), but not in
Ube3am/p mice (red plot; paired t test, p 
 0.05).
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behavior. We also found that Ube3a imprinting is uniquely re-
laxed in neurons within the SCN. Thus, it remains possible that
homozygous Ube3a deletion could produce a stronger circadian
phenotype. However, RNAi-mediated Ube3a knockdown in hu-
man U2OS cells produced a similarly small (0.6 h) period
lengthening, suggesting that even homozygous Ube3a deletion is
unlikely to markedly impair circadian clock function.
Observational studies of AS individuals, obtained from sur-
veys of parents and caregivers, indicate that AS individuals have
decreased nighttime sleep amounts and difficulty falling and stay-
ing asleep (Bruni et al., 2004; Didden et al., 2004; Goldman et al.,
2012; Thibert et al., 2013; Larson et al., 2015). These studies have
led to the idea that individuals with AS generally have less need
for nighttime sleep. EEG/EMG recordings of nighttime sleep sup-
port these observations, and further suggest that children with AS
also have reduced levels of REM sleep and decreased sleep effi-
ciency (Miano et al., 2004). EEG sleep studies in individuals with
AS, however, were limited to the 7–9 h corresponding to bedtime,
and did not include the daytime/active period. Our results sug-
gest that nighttime sleep deficits that affect individuals with AS
may be due, at least in part, to specific changes in sleep-pressure
accumulation that are most prominent during the daytime. Thus,
EEG sleep studies in individuals with AS during the day may
reveal broader differences in sleep homeostasis. Accordingly, our
data raise the possibility that interventions that affect sleep regu-
lation during the daytime may substantially improve the overall
nighttime sleep profile of individuals with AS.
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